BMJ on changes to the FDA
Published by AWills January 14th, 2007 in NewsThe current user fee legislation expires on September 30th of this year, and the reauthorization will most probably introduce new drug safety legislation if Congress finds it necessary. The editorial looks some legislation that may be added, including more resources, independent drug safety investigations, better communication, and more authority in the area of adverse events.
No Responses to “BMJ on changes to the FDA”
Please Wait
Leave a Reply
You must log in to post a comment.